<h1 itemprop="aspect"> <strong>Duetact Side Effects</strong></h1><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2013/01/duetact-84x84.jpg?1df917" class="attachment-84x84 wp-post-image" alt="Duetact" title="Duetact" pagespeed_url_hash="2713355062" onload="pagespeed.CriticalImages.checkImageForCriticality(this);"/></div><h2>Serious Adverse Side Effects</h2> <b>Duetact </b><b>| </b><b>Pioglitazone Hydrochloride And Glimepiride</b> has many serious adverse side effects associated with it, such as:<ul><li>Cardiovascular side effects like heart failure</li><li>Hepatic side effects like <a href="http://en.wikipedia.org/wiki/Hepatotoxicity" target="_blank" rel="nofollow">hepatotoxicity</a>, or chemically-driven liver damage</li><li>Renal side effects like tumors of the bladder</li><li>Respiratory side effects like pneumonia</li></ul><h2>Common Adverse Side Effects</h2> <b>Duetact </b><b>| </b><b>Pioglitazone Hydrochloride And Glimepiride</b> has more common and less severe adverse side effects associated with it, such as:<ul><li>Cardiovascular side effects like edema (swelling), and edema of lower extremities</li><li>Endocrine metabolic side effects like hypoglycemia (low blood sugar) and weight gain</li><li>Gastrointestinal side effects like diarrhea and nausea</li><li>Musculoskeletal side effects like pain in the limbs</li><li>Neurological side effects like headache</li><li>Renal side effects like urinary tract infections</li><li>Respiratory side effects like upper respiratory infections</li></ul></div><div class="v" id="tab2" ><h2 itemprop="aspect"> <strong> Warnings & Recalls for Duetact </strong></h2><h1>Black Box Warning</h1> The pioglitazone hydrochloride component of <b>Duetact </b><b>| </b><b>Pioglitazone Hydrochloride And Glimepiride</b>, may cause or worsen congestive heart failure.  Patients should be monitored for signs and symptoms of heart failure after starting this drug.  <b>Duetact </b><b>| </b><b>Pioglitazone Hydrochloride And Glimepiride</b> is not recommended for patients with symptomatic heart failure.<h2>Contraindications</h2> <b>Duetact </b><b>| </b><b>Pioglitazone Hydrochloride And Glimepiride</b> has contraindications such as:<ul><li>Heart failure</li><li>Hypersensitivity to pioglitazone or glimepiride</li><li>Diabetic ketoacidosis (with or without coma)</li></ul><h2>Who Should Not Take This Drug</h2> <b>Duetact </b><b>| </b><b>Pioglitazone Hydrochloride And Glimepiride</b> should never be taken by the following patients with these preexisting conditions:<ul><li>Patients with congestive heart failure</li><li>Patients with active bladder cancer</li><li>Patients with cardiovascular mortality risks</li><li>Female patients are at an increased risk of bone fracture</li><li>Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiencies</li><li>Patients who drink alcohol or take more than one glucose-lowering agents are at an increased risk of hypoglycemia if they were to take this drug</li><li>Patients with liver disease</li><li>Female patients who are premenopausal are at increased risk of pregnancy</li><li>Prolonged use of this drug is not recommended</li><li>Patients undergoing surgery, fever, trauma or infections</li><li>Patients with type 1 diabetes</li><li>Those who are taking leflunomide, gatifloxacin or teriflunomide.</li></ul><h2>Pregnancy Warning</h2> <b>Duetact </b><b>| </b><b>Pioglitazone Hydrochloride And Glimepiride</b> has been given a pregnancy category rating of “C” by the FDA.  Both glimepiride and pioglitazone hydrochloride have been given grades of “C”.</div><div class="v" id="tab3" ><h2 itemprop="aspect"> <strong> Duetact Treatment and Use </strong></h2><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2013/01/duetact-84x84.jpg?1df917" class="attachment-84x84 wp-post-image" alt="Duetact" title="Duetact" pagespeed_url_hash="2713355062" onload="pagespeed.CriticalImages.checkImageForCriticality(this);"/></div><p><b>Duetact </b><b>| </b><b>Pioglitazone Hydrochloride And Glimepiride </b>is a drug that treats <a target="_blank" href="http://en.wikipedia.org/wiki/Diabetes_mellitus" target="_blank" rel="nofollow">diabetes mellitus</a>.  A new synthesis of the popular and controversial Actos drug, <b>Duetact </b><b>| </b><b>Pioglitazone Hydrochloride And Glimepiride</b> is a combination of 30mg of pioglitazone and either 2 or 4mg of glimepiride.  This drug is a prescription used with both diet and exercise to improve blood sugar (glucose) control in adults with diabetes mellitus.  As such, this drug has not been tested for efficacy and safety in children or adolescents.</p><h2>How This Drug Works</h2><p>The fixed dose of pioglitazone and glimepiride is an anti-hypoglycemic  synthesis made into <b>Duetact </b><b>| </b><b>Pioglitazone Hydrochloride And Glimepiride</b>.  These two agents act differently to achieve glycemic control in patients with diabetes mellitus.  Pioglitazone hydrochloride is a member of thiazolidinedione class, which are known to be insulin-sensitizing agents working primarily by improving the utilization of peripheral glucose.  Glimepiride is acknowledged to lower blood glucose in patients with diabetes mellitus by the stimulation of the release of insulin from pancreatic beta cells which are functioning.  It also produces an increase in the sensitivity of peripheral tissues to insulin via extra-pancreatic mechanisms.</p><h2>Dosage Information</h2><p>The dosage of <b>Duetact </b><b>| </b><b>Pioglitazone Hydrochloride And Glimepiride</b> in anti-hypoglycemic therapy for the management of diabetes mellitus should be individualized in each patient on the basis of both tolerance and effectiveness.  Failure to follow the appropriate guidelines for this drug can precipitate <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001423/" target="_blank" rel="nofollow">hypoglycemia</a>.  In elderly, malnourished or debilitated patients with diabetes mellitus or in patients with hepatic or renal insufficiencies, the initial doses of this drug should be as conservative as possible to avoid instances of hypoglycemia.</p><ul><li>For patients already on glimepiride, this drug should be initiated at 30mg/2mg or 30mg/4mg tablets once daily and then adjusted after an assessment</li><li>For patients already on pioglitazone, this drug should be initiated at 30mg/4mg tablets once daily and then adjusted after an assessment</li></ul></div><div class="v" id="tab4" ><h2 itemprop="aspect"> Other Names for Duetact</h2><h2>Brand Name</h2><br/><ul><br/><li>Duetact</li><br/></ul><br/><h2>Generic Name</h2><br/><ul><br/><li>Pioglitazone Hydrochloride And Glimepiride</li><br/></ul></div><div class="v" id="tab5" ><h2 itemprop="aspect"> <strong> Lawsuits & Legal Information for Duetact </strong></h2>